Aldeyra Therapeutics (ALDX) Expected to Announce Quarterly Earnings on Thursday

Aldeyra Therapeutics (NASDAQ:ALDX) is expected to be issuing its quarterly earnings data before the market opens on Thursday, March 6th. Analysts expect the company to announce earnings of $0.03 per share for the quarter.

Aldeyra Therapeutics Trading Up 1.4 %

Shares of NASDAQ ALDX opened at $6.59 on Thursday. Aldeyra Therapeutics has a 1 year low of $2.71 and a 1 year high of $6.92. The company has a current ratio of 6.80, a quick ratio of 6.80 and a debt-to-equity ratio of 0.18. The company has a 50 day simple moving average of $5.41 and a 200 day simple moving average of $5.36.

Aldeyra Therapeutics Company Profile

Aldeyra Therapeutics is a clinical-stage biotechnology company focused on the development of novel therapies with the potential to improve the lives of patients with immune-mediated diseases. Two of the company’s lead compounds, reproxalap and ADX-629, target reactive aldehyde species (RASP), which are elevated in ocular and systemic inflammatory disease, leading to elevated levels of cytokine release via activation of a broad array of inflammatory factors, including NF-κB, inflammasomes, and Scavenger Receptor A.